ArticlePloS one2025
Synergistic effects of Rhynchosia nulubilis and Polygonum multiflorum extract combination on cell proliferation via targeting IGFBP-1 & NT-3 and cytotoxicity suppression in testosterone-induced human dermal papilla cells.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research Progress on Anti-Aging with Natural Products: From Pathway Modulation to AI-Driven Discovery.Biomolecules · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study examines the synergistic effects of extracts from Rhynchosia nulubilis (RN) and Polygonum multiflorum (PM) on the proliferation of human dermal papilla cells (hDPCs) and the alleviation of testosterone-induced cytotoxicity. Human dermal papilla cells (hDPCs) were treated with varying concentrations of RN and PM extracts, administered both individually and in multiple combinations at different ratios. The findings indicated that a 4:1 combination of RN and PM extracts significantly enhanced hDPC proliferation relative to the individual extracts, particularly in the presence of testosterone, which induced cytotoxicity. A significant synergistic effect was observed at a 4:1 ratio, resulting in the creation of a human growth factor array to identify targets associated with this synergy. The combined-extract group exhibited elevated levels of two significant growth factors: insulin-like growth factor-binding protein-1 (IGFBP-1) and neurotrophin-3 (NT-3). This was additionally validated through Western blot analysis. HPLC analysis identified six compounds and screening was conducted. As a result, genistein derived from RN and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (2354-T2G) sourced from PM may be responsible for these effects. This is the first study to illustrate the significant synergistic effect of the combination of RN and PM, suggesting a potential treatment strategy that boosts the efficacy of natural compounds through synergy. The results suggest that the combined extracts could be useful as an effective treatment strategy for hair loss and associated disorders. Furthermore, this synergy-based approach has potential applications in future research on natural products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.